Drug Profile
Ofloxacin ophthalmic solution
Alternative Names: Exocin; Ocuflox; Oflovid; Oflox; TarividLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company; Santen Pharmaceutical
- Class Antibacterials; Fluoroquinolones; Small molecules
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Corneal ulcer; Infectious conjunctivitis; Ophthalmic infections
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 03 Apr 2006 Daiichi Pharmaceutical has merged with Sankyo to form Daiichi Sankyo Inc
- 27 Nov 2000 Dura Pharmaceuticals has been acquired by Elan Corporation